28.61
price up icon0.21%   0.06
after-market Handel nachbörslich: 28.54 -0.07 -0.24%
loading
Schlusskurs vom Vortag:
$28.55
Offen:
$28.61
24-Stunden-Volumen:
60,539
Relative Volume:
0.45
Marktkapitalisierung:
$406.58M
Einnahmen:
$138.20M
Nettoeinkommen (Verlust:
$5.52M
KGV:
75.29
EPS:
0.38
Netto-Cashflow:
$9.86M
1W Leistung:
+0.95%
1M Leistung:
-5.83%
6M Leistung:
-25.26%
1J Leistung:
+12.68%
1-Tages-Spanne:
Value
$28.04
$28.97
1-Wochen-Bereich:
Value
$27.02
$28.97
52-Wochen-Spanne:
Value
$25.17
$42.44

Surmodics Inc Stock (SRDX) Company Profile

Name
Firmenname
Surmodics Inc
Name
Telefon
(952) 500-7000
Name
Adresse
9924 W 74TH ST, EDEN PRAIRIE, MN
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
SRDX's Discussions on Twitter

Vergleichen Sie SRDX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
SRDX
Surmodics Inc
28.61 406.58M 138.20M 5.52M 9.86M 0.38
Medical Devices icon
ABT
Abbott Laboratories
131.73 218.91B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.05 139.37B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
348.12 134.90B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
83.37 106.90B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
70.60 41.45B 5.72B 4.17B 259.90M 6.97

Surmodics Inc Stock (SRDX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-07 Hochstufung Lake Street Hold → Buy
2023-06-13 Hochstufung Needham Hold → Buy
2023-02-13 Herabstufung Needham Buy → Hold
2020-07-23 Hochstufung Needham Hold → Buy
2019-12-11 Herabstufung Needham Buy → Hold
2019-11-01 Herabstufung Lake Street Buy → Hold
2019-08-01 Bestätigt Needham Buy
2019-05-02 Bestätigt Lake Street Buy
2019-05-02 Bestätigt Needham Buy
2019-02-21 Bestätigt Needham Buy
2018-05-16 Bestätigt Needham Buy
2018-03-01 Hochstufung Sidoti Neutral → Buy
2018-02-28 Bestätigt Lake Street Buy
2018-02-28 Eingeleitet Needham Buy
2017-07-14 Eingeleitet Lake Street Buy
2016-11-21 Herabstufung Barrington Research Outperform → Mkt Perform
2016-10-06 Herabstufung Sidoti Buy → Neutral
2016-05-03 Bestätigt Barrington Research Outperform
2015-08-06 Bestätigt Barrington Research Outperform
2015-03-27 Eingeleitet Dougherty & Company Buy
2014-02-25 Eingeleitet Laidlaw Buy
2013-08-01 Hochstufung Feltl & Co. Buy → Strong Buy
2012-11-12 Bestätigt Barrington Research Outperform
Alle ansehen

Surmodics Inc Aktie (SRDX) Neueste Nachrichten

pulisher
03:04 AM

Surmodics' SurVeil DCB Matches IN.PACT Admiral In Efficacy With Lower Drug Dose In Global Trial - Nasdaq

03:04 AM
pulisher
07:49 AM

Surmodics (SRDX) Publishes Promising Clinical Trial Results for SurVeil DCB | SRDX Stock News - GuruFocus

07:49 AM
pulisher
07:24 AM

Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon | SRDX Stock News - GuruFocus

07:24 AM
pulisher
07:00 AM

Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon - Business Wire

07:00 AM
pulisher
05:33 AM

FTC Expands Lawsuit Against GTCR Over Surmodics Acquisition - MSN

05:33 AM
pulisher
Apr 18, 2025

Illinois, Minnesota join FTC challenge against $627M Surmodics buyout - MedTech Dive

Apr 18, 2025
pulisher
Apr 17, 2025

Illinois joins FTC suit to block GTCR’s takeover of Surmodics - Crain's Chicago Business

Apr 17, 2025
pulisher
Apr 17, 2025

AG Ellison Joins Suit to Block Surmodics Acquisition - Twin Cities Business

Apr 17, 2025
pulisher
Apr 08, 2025

(SRDX) Long Term Investment Analysis - news.stocktradersdaily.com

Apr 08, 2025
pulisher
Apr 07, 2025

Surmodics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire

Apr 07, 2025
pulisher
Apr 04, 2025

SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System - Yahoo Finance

Apr 04, 2025
pulisher
Apr 03, 2025

Surmodics launches Pounce XL for peripheral artery clot removal By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Surmodics launches Pounce XL thrombectomy system - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

Surmodics launches Pounce XL for peripheral artery clot removal - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

Revolutionary Blood Clot Treatment: Pounce XL Shows 80% Success Rate in Just 20 Minutes - Stock Titan

Apr 03, 2025
pulisher
Mar 29, 2025

Gardner Lewis Asset Management L P Raises Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat

Mar 29, 2025
pulisher
Mar 29, 2025

Learn to Evaluate (SRDX) using the Charts - news.stocktradersdaily.com

Mar 29, 2025
pulisher
Mar 28, 2025

PE Firm Hits Back Against Medical Device Coating Challenge - Law360

Mar 28, 2025
pulisher
Mar 25, 2025

FTC Challenges Medical Device Coatings Deal - Medical Product Outsourcing

Mar 25, 2025
pulisher
Mar 24, 2025

Zacks Research Decreases Earnings Estimates for Surmodics - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

Bank of New York Mellon Corp Sells 2,966 Shares of Surmodics, Inc. (NASDAQ:SRDX) - Defense World

Mar 23, 2025
pulisher
Mar 18, 2025

Here's Why You Should Retain Surmodics Stock in Your Portfolio Now - Zacks Investment Research

Mar 18, 2025
pulisher
Mar 13, 2025

FTC’s First Merger Challenge Under New Leadership Signals Return to Traditional Antitrust Theories in Private Equity Deals - JD Supra

Mar 13, 2025
pulisher
Mar 12, 2025

GTCR / Surmodics: Four Key Takeaways for M&A Antitrust from the First FTC Merger Challenge Under Trump - JD Supra

Mar 12, 2025
pulisher
Mar 10, 2025

FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics - Yahoo Finance

Mar 10, 2025
pulisher
Mar 10, 2025

Medical Coating Market Projected To Witness Substantial Growth, 2025-2032: Freudenberg Medical Europe GmbH, - EIN News

Mar 10, 2025
pulisher
Mar 09, 2025

Surmodics (NASDAQ:SRDX) Stock Rating Upgraded by Lake Street Capital - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Lake Street Upgrades Surmodics (SRDX) - Nasdaq

Mar 08, 2025
pulisher
Mar 07, 2025

SRDX Stock Falls Following Plan for Legal Action Against FTC Challenge - MSN

Mar 07, 2025
pulisher
Mar 07, 2025

Where are the Opportunities in (SRDX) - Stock Traders Daily

Mar 07, 2025
pulisher
Mar 07, 2025

Deal Dispatch: Clock Ticks On TikTok, Raizen Explores Asset Sale, Investors Urge Walgreens To Go Private - Benzinga

Mar 07, 2025
pulisher
Mar 07, 2025

FTC Sues to Block Sale of Surmodics - PlasticsToday

Mar 07, 2025
pulisher
Mar 07, 2025

FTC targets GTCR in agency's first merger challenge under new Trump term - Crain's Chicago Business

Mar 07, 2025
pulisher
Mar 07, 2025

FTC challenges private equity firm’s acquisition of Surmodics - MassDevice

Mar 07, 2025
pulisher
Mar 07, 2025

FTC challenges $627M private equity takeover of Surmodics - MedTech Dive

Mar 07, 2025
pulisher
Mar 07, 2025

Surmodics remains committed to GTCR merger despite US FTC suit - MLex

Mar 07, 2025
pulisher
Mar 07, 2025

Why Surmodics Stock Is Falling On Friday - Benzinga India

Mar 07, 2025
pulisher
Mar 07, 2025

Surmodics says it will defend proposed acquisition by GTCR against FTC lawsuit - pehub.com

Mar 07, 2025
pulisher
Mar 07, 2025

Lake Street Upgrades SurModics to Buy From Hold, Price Target is $43 -March 07, 2025 at 08:46 am EST - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

Surmodics Vows to Oppose FTC Decision to Block GTCR Deal -March 07, 2025 at 04:39 am EST - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

Rhumbline Advisers Boosts Stake in Surmodics, Inc. (NASDAQ:SRDX) - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Surmodics contests FTC challenge to GTCR acquisition By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Surmodics Responds To FTC Challenge, Commits To Completing Merger With GTCR - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

US FTC sues to block private equity purchase of medical company - Reuters.com

Mar 06, 2025
pulisher
Mar 06, 2025

Surmodics Says Disagrees With FTC's Decision And Remains Committed To Completing Merger with GTCR - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

Surmodics contests FTC challenge to GTCR acquisition - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Will FTC Block Surmodics' $627M Deal? Company Ready for Court Battle - StockTitan

Mar 06, 2025
pulisher
Mar 06, 2025

Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR - Business Wire

Mar 06, 2025
pulisher
Mar 06, 2025

FTC Challenges PE Firm's Medical Device Coatings Deal - Law360

Mar 06, 2025
pulisher
Mar 06, 2025

US FTC sues to block GTCR-Surmodics deal - MLex

Mar 06, 2025
pulisher
Mar 06, 2025

FTC sues to block GTCR’s $627M Surmodics acquisition - Modern Healthcare

Mar 06, 2025

Finanzdaten der Surmodics Inc-Aktie (SRDX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices ZBH
$97.44
price up icon 1.32%
medical_devices PHG
$24.14
price up icon 3.65%
medical_devices STE
$222.77
price up icon 1.82%
$66.33
price up icon 0.33%
$61.65
price up icon 1.93%
medical_devices EW
$70.60
price up icon 2.02%
Kapitalisierung:     |  Volumen (24h):